• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Dr. Reddy Laboratories

Dr. Reddy Laboratories

Dr Reddy Laboratories Ltd ADR RDY

Last Price$41.82Day Change (%)-0.99%
Open Price$41.55Day Change ($)-0.42
Day Range41.39–41.9952-Week Range40.68–68.00

As of Fri 2/12/2016 5:11:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Dr. Reddy’s Q3 and 9M FY16 Financial Results

    Dr. Reddy’s Q3 and 9M FY16 Financial Results

  2. Stockton is Bankrupt: Now What?

    Plus, a top executive bolts from eBay, Brazilian telcos get cheap, and more.

  3. Dr . Reddy ’s Laboratories Receives USFDA Tentative Approval for Zenavod™ (doxycycline) Capsules, 40 mg for the Treatment of Rosacea in Adults

    Dr . Reddy ’s Laboratories Receives USFDA Tentative Approval for Zenavod™ (doxycycline) Capsules, 40 mg for the Treatment of Rosacea in Adults

  4. Dr . Reddy ’s Laboratories Ltd. Receives FDA Approval for ZEMBRACE™SymTouch™ (sumatriptan succinate) Injection for the Acute Treatment of Migraines in Adults

    Dr . Reddy ’s Laboratories Ltd. Receives FDA Approval for ZEMBRACE™SymTouch™ (sumatriptan succinate) Injection for the Acute Treatment of Migraines in Adults

  5. Dr. Reddy's to Release Q3FY16 Results on Feb 9, 2016; Earnings Call Slated for Feb 9, 6:30 PM IST / 8:00 AM EST

    Dr. Reddy's to Release Q3FY16 Results on Feb 9, 2016; Earnings Call Slated for Feb 9, 6:30 PM IST / 8:00 AM EST

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.